CORONA Remedies Limited (BOM:544644)

Market Cap	136.76B
Revenue (ttm)	14.79B +19.2%
Net Income	1.99B +25.0%
EPS	32.55 +25.1%
Shares Out	n/a
PE Ratio	68.71
Forward PE	52.88
Dividend	10.00 (0.45%)
Ex-Dividend Date	Jun 19, 2026

Volume	11,184
Open	2,219.35
Previous Close	2,200.15
Day's Range	2,185.05 - 2,251.75
52-Week Range	1,336.95 - 2,261.40
Beta	n/a
Analysts	Strong Buy
Price Target	2,304.67 (+3.06%)
Earnings Date	Nov 14, 2026

About CORONA Remedies

CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women’s healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, nutraceuticals, gastroenterology, and other therapeutic areas. The company was incorporated in 2004 and is based in Ahmedabad, India.

• Industry: Pharmaceutical Preparations
• Founded: 2004
• Employees: 5,153
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544644

Financial Performance

In fiscal year 2026, CORONA Remedies's revenue was 14.03 billion, an increase of 17.28% compared to the previous year's 11.96 billion. Earnings were 1.85 billion, an increase of 23.88%.

Analyst Summary

According to 3 analysts, the average rating for 544644 stock is "Strong Buy." The 12-month stock price target is ₹2,305, which is an increase of 3.06% from the latest price.

Price Target

₹2,305

(3.06% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 13, 2026

Data Sources Report a data error